Chemoinformaics analysis of Methyl 4-hydroxy-3,5-dimethoxybenzoate
| Molecular Weight | 212.201 | nRot | 3 |
| Heavy Atom Molecular Weight | 200.105 | nRig | 7 |
| Exact Molecular Weight | 212.068 | nRing | 1 |
| Solubility: LogS | -3.056 | nHRing | 0 |
| Solubility: LogP | 1.644 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 28.7115 |
| nHD | 1 | BPOL | 18.1145 |
| QED | 0.762 |
| Synth | 1.728 |
| Natural Product Likeliness | 0.321 |
| NR-PPAR-gamma | 0.075 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.016 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.656 |
| MDCK | 0.0000271 |
| BBB | 0.8 |
| PPB | 0.773714 |
| VDSS | 0.546 |
| FU | 0.181814 |
| CYP1A2-inh | 0.905 |
| CYP1A2-sub | 0.955 |
| CYP2c19-inh | 0.191 |
| CYP2c19-sub | 0.809 |
| CYP2c9-inh | 0.105 |
| CYP2c9-sub | 0.773 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.734 |
| CYP3a4-inh | 0.059 |
| CYP3a4-sub | 0.282 |
| CL | 11.062 |
| T12 | 0.931 |
| hERG | 0.03 |
| Ames | 0.014 |
| ROA | 0.011 |
| SkinSen | 0.418 |
| Carcinogencity | 0.024 |
| EI | 0.96 |
| Respiratory | 0.095 |
| NR-Aromatase | 0.47 |
| Antiviral | No |
| Prediction | 0.873199 |